Oncolytics Biotech Inc. to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference

Strategic Insights -

Oncolytics Biotech Inc., a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, will present a corporate overview at the Rodman & Renshaw 3rd Annual Global Healthcare Conference on May 16, 2006. Dr. Brad Thompson, President and CEO, will lead the presentation at 11:55 a.m. (5:55 a.m. ET) at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. The event will be webcast live, allowing investors and stakeholders to participate remotely.

Key Takeaways:

  • Oncolytics Biotech Inc. will present a corporate overview at the Rodman & Renshaw 3rd Annual Global Healthcare Conference on May 16, 2006.
  • Dr. Brad Thompson, President and CEO, will lead the presentation at 11:55 a.m. (5:55 a.m. ET) at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco.
  • The company's clinical program includes Phase I and Phase I/II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation.
  • The presentation and webcast times are subject to change, and investors are advised to log on 15 minutes in advance of the presentation to register and download any necessary software.
  • Oncolytics' clinical trials are testing the efficacy of REOLYSIN(R) as a cancer treatment, with a focus on the development of oncolytic viruses as potential cancer therapeutics.

Statistics:

  • The company's clinical program includes multiple Phase I and Phase I/II human trials using REOLYSIN(R).
  • REOLYSIN(R) is Oncolytics Biotech Inc.'s proprietary formulation of the human reovirus.
  • The company has established partnerships and collaborations with various organizations to advance the development of REOLYSIN(R) as a cancer treatment.

Sources:

  • Oncolytics Biotech Inc.

+ Company website: www.oncolyticsbiotech.com

+ Press release: PRNewswire

  • Rodman & Renshaw 3rd Annual Global Healthcare Conference

+ Event website: N/A

+ Publication details: N/A